TREATABLE MORTALITY IN GENITOURINARY SYSTEM DISEASE
Introduction: In recent years there has been an increase of the genitourinary system disease. For instance, according to the Global Burden of Disease data in 2019 about 404.61 million cases registered and 236,790 deaths. In addition, between 1990 to 2019, the mortality rate increased 2.4 times where the age-standardized death rate rose fr om 2.77 to 3.13 per 100,000 population.
The aim of our study to calculate the treatable mortality from genitourinary system disease in Kazakhstan.
Methods: The mortality data from genitourinary system disease was obtained from the Bureau of National Statistics of the Agency for Strategic Planning and Reforms of the Republic of Kazakhstan (https://stat.gov.kz). The data was generated based on criteria and indicators developed by countries of the Organization for Economic Co-operation and Development (OECD), which include: the number of deaths by age categories and causes of death. Data presented for the period from 2015 to 2021, disaggregated by the age group of 5 years.
Results: Treatable mortality from renal failure in the whole of the Kazakhstan increased from 6.76 to 11.14 per 100,000 population, in particular, the growth was more than three times higher in 2021 compared to 2015 in in six regions of Kazakhstan. In Kazakhstan, the high rate of treatable mortality from renal failure in 2021 was within 10 or more per 100,000 of the population in nine regions.
Conclusion: An analysis of international studies shows an increase in the burden of diseases from genitourinary system, therefore, there is a need to improve prevention and treatment activities, especially in regions wh ere there is an increase in treatable deaths.
Number of Views: 172
Category of articles:
Original articles
Bibliography link
Kosherbayeva L., Samambayeva A., Akhtaeva N., Tolganbayeva K., Imamatdinova A. Treatable mortality in genitourinary system disease // Nauka i Zdravookhranenie [Science & Healthcare]. 2023, (Vol.25) 1, pp. 79-85. doi 10.34689/SH.2023.25.1.010 Кошербаева Л., Самамбаева А., Ахтаева Н., Толганбаева К., Имаматдинова А. Излечимая смертность при заболеваниях мочеполовой системы // Наука и Здравоохранение. 2023. 1(Т.25). С. 79-85. doi 10.34689/SH.2023.25.1.010Related publications:
A COMPARATIVE ANALYSIS OF 24-HOUR DIETARY RECALLS AND FOOD FREQUENCY QUESTIONNAIRES ADMINISTERED SIMULTANEOUSLY IN THE KAZAKHSTANI POPULATION
ANALYSIS OF PATIENT SATISFACTION WITH THE QUALITY OF ORGANIZATION OF TREATMENT IN FOREIGN CLINICS
CLINICAL AND LABORATORY PREDICTORS OF THE SEVERITY OF COVID-19 INFECTION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
POST-MARKETING STUDY OF THE CLINICAL EFFICACY AND SAFETY OF GRIPMAX NOS IN THE TREATMENT OF ACUTE RESPIRATORY INFECTIONS OF THE UPPER RESPIRATORY TRACT
EXPERIENCE IN IMPROVING SURGICAL TREATMENT WHEN IMPOSING A STOMA IN CHILDREN WITH HIRSPRUNG'S DISEASE